Recombinogenic activity of Pantoprazole® in somatic cells of Drosophila melanogaster
AUTOR(ES)
Lopes, Jeyson Césary, Machado, Nayane Moreira, Saturnino, Rosiane Soares, Nepomuceno, Júlio César
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
2015-03
RESUMO
Pantoprazole® is one of the leading proton pump inhibitors (PPIs) used in the treatment of a variety of diseases related to the upper gastrointestinal tract. However, studies have shown an increased risk of developing gastric cancer, intestinal metaplasia and hyperplasia of endocrine cells with prolonged use. In the present study, the somatic mutation and recombination test (SMART) was employed to determine the mutagenic effects of Pantoprazole on Drosophila melanogaster. Repeated treatments with Pantoprazole were performed on 72-hour larvae of the standard (ST) and high bioactivation (HB) crosses at concentrations of 2.5, 5.0, and 10.0 μM. In addition, doxorubicin (DXR) was administered at 0.4 mM, as a positive control. When administered to ST descendants, total number of spots were statistically significant at 2.5 and 5.0 μM concentrations. For HB descendants, a significant increase in the total number of spots was observed among the marked transheterozygous (MH) flies. Through analysis of balancer heterozygous (BH) descendants, recombinogenic effects were observed at all concentrations in descendants of the HB cross. In view of these experimental conditions and results, it was concluded that Pantoprazole is associated with recombinogenic effects in Drosophila melanogaster.
Documentos Relacionados
- Viability of Homozygous Deficiencies in Somatic Cells of DROSOPHILA MELANOGASTER
- Somatic Effects of P Element Activity in Drosophila melanogaster: Pupal Lethality
- Behavior of Somatic Cells Homozygous for Zygotic Lethals in DROSOPHILA MELANOGASTER
- Lack of Spontaneous Sister Chromatid Exchanges in Somatic Cells of DROSOPHILA MELANOGASTER
- Lack of Spontaneous Sister Chromatid Exchanges in Somatic Cells of DROSOPHILA MELANOGASTER